TB Alliance manages the largest pipeline of new TB drugs in history.
Reporting to the Chief Executive Officer, the Senior Vice-President of Research and Development will have primary responsibility for the planning and advancement of TB Alliance R&D pipeline. The Senior Vice-President of Research and Development will oversee and integrate all R&D functions including discovery research, preclinical, clinical development and operations, and regulatory affairs. The Senior Vice-President of Research and Development will also provide the necessary vision to develop strategic alliances and make key additions to the product portfolio. This individual will have a strong track record of drug approvals, ideally in both developed and developing countries. This individual will be a senior leader within the organization, contributing to the strategic direction of the TB Alliance and participating with other senior management in all key areas, including resource mobilization, financial management, market access and delivery, policy, advocacy, & communications. program management, and organizational development. This person will work with the Board of Directors, Scientific Advisory Committee (SAC), TB Alliance funders and prospective funders, key external stakeholders and decision makers, and the media to ensure that the TB Alliance’s vision and performance meets the needs of a global patient population.
To apply for this position, send resumes and cover letters to firstname.lastname@example.org. Please include the position title in the subject line.
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.
With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website: www.tballiance.org.